Grifols (GRFS) Begins Integration of Talecris Biotherapeutics
Tweet
Share
E-mailGet Alerts GRFS Hot Sheet
Join SI Premium – FREE
Grifols (Nasdaq: GRFS) reports that it has begun to merge its operations with Talecris Biotherapeutics in order to function as one company, following its acquisition of Talecris on June 1, 2011.
Talecris will adopt the Grifols, Inc. name as the North American corporate subsidiary of Grifols, S.A., the Spanish holding company based in Barcelona, Spain.
Talecris will adopt the Grifols, Inc. name as the North American corporate subsidiary of Grifols, S.A., the Spanish holding company based in Barcelona, Spain.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Willdan acquires KCS Corporation to expand power delivery services
- Neighborhood Intelligence board launches review of blockchain asset holdings
- OLB Group narrows net loss 50% as revenue falls in Q2 2026
Create E-mail Alert Related Categories
Corporate News, Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
